|
Rep. Dan Reitz
Filed: 3/16/2011
| | 09700HB1494ham004 | | LRB097 05137 CEL 53200 a |
|
|
1 | | AMENDMENT TO HOUSE BILL 1494
|
2 | | AMENDMENT NO. ______. Amend House Bill 1494 by replacing |
3 | | everything after the enacting clause with the following:
|
4 | | "Section 5. The Illinois Optometric Practice Act of 1987 is |
5 | | amended by changing Section 15.1 as follows:
|
6 | | (225 ILCS 80/15.1)
|
7 | | (Section scheduled to be repealed on January 1, 2017)
|
8 | | Sec. 15.1. Diagnostic and therapeutic authority.
|
9 | | (a) For purposes of the Act, "ocular pharmaceutical
agents" |
10 | | means topical anesthetics, topical mydriatics, topical
|
11 | | cycloplegics, topical miotics and mydriatic reversing agents, |
12 | | anti-infective agents,
anti-allergy agents,
anti-glaucoma |
13 | | agents (except oral carbonic anhydrase inhibitors, which may be |
14 | | prescribed only in a quantity sufficient to provide treatment |
15 | | for up to 72 hours),
anti-inflammatory agents (except oral |
16 | | steroids), over-the-counter agents, and analgesic
agents , |
|
| | 09700HB1494ham004 | - 2 - | LRB097 05137 CEL 53200 a |
|
|
1 | | anti-dry eye agents, and agents for the treatment of |
2 | | hypotrichosis . |
3 | | (a-3) In addition to ocular pharmaceutical agents that fall |
4 | | within the categories set forth in subsection (a) of this |
5 | | Section, the Board may add a pharmaceutical agent approved by |
6 | | the FDA or class of agents for the purpose of the diagnosis or |
7 | | treatment of conditions of the eye and adnexa after |
8 | | consideration of the agent's systemic effects, side effects, |
9 | | and the use of the agent within the practice of optometry. The |
10 | | Board shall consider requests for additional agents and make |
11 | | recommendations within 90 days after the receipt of the |
12 | | request. |
13 | | Within 45 days after the Board's recommendation to the |
14 | | Department of a pharmaceutical agent or class of agents, the |
15 | | Department shall promulgate rules necessary to allow for the |
16 | | prescribing or administering of the pharmaceutical agent or |
17 | | class of agents under this Act. |
18 | | (a-5) Ocular pharmaceutical agents administered by |
19 | | injection may be used only for the treatment of anaphylaxis. |
20 | | (a-10) Oral pharmaceutical agents may be prescribed for a |
21 | | child under 5 years of age only in consultation with a |
22 | | physician licensed to practice medicine in all its branches. |
23 | | (a-15) The authority to prescribe a Schedule III, IV, or V |
24 | | controlled substance shall include only analgesic agents in a |
25 | | quantity sufficient to provide treatment for up to 72 hours. |
26 | | The prescription of a Schedule II controlled substance is |
|
| | 09700HB1494ham004 | - 3 - | LRB097 05137 CEL 53200 a |
|
|
1 | | prohibited.
|
2 | | (b) A licensed optometrist may remove superficial foreign |
3 | | bodies from the human eye and adnexa and may give orders for |
4 | | patient care to a nurse licensed to practice under Illinois |
5 | | law.
|
6 | | (c) An optometrist's license shall be revoked or suspended |
7 | | by the Department
upon recommendation of the Board based upon |
8 | | either of the
following causes: |
9 | | (1) grave or repeated misuse of any ocular
|
10 | | pharmaceutical agent; and |
11 | | (2) the use of any agent or procedure in the course of |
12 | | optometric practice
by an optometrist not properly |
13 | | authorized under this Act. |
14 | | (d) The Secretary of Financial and Professional Regulation |
15 | | shall notify
the Director of Public Health as to the categories |
16 | | of ocular
pharmaceutical agents permitted for use by an |
17 | | optometrist. The Director of Public Health shall in turn
notify |
18 | | every licensed pharmacist in the State of the categories of |
19 | | ocular
pharmaceutical agents that can be utilized and |
20 | | prescribed by an optometrist.
|
21 | | (Source: P.A. 94-787, eff. 5-19-06; 95-242, eff. 1-1-08.)
|
22 | | Section 99. Effective date. This Act takes effect upon |
23 | | becoming law.".
|